Concepedia
Statistics
Publications
12
Citations
518
H-Index
Active since
1999
Affiliations
Regenxbio (United States)(Current)
AstraZeneca (Germany)
Diabetes UK
Imperial College London Diabetes Centre
Imperial College London
Nicholas Buss is an author at Regenxbio (United States) specializing in medicine, cell biology, and neuroimmunology.
Top concepts
MedicineCell BiologyNeurologyBiochemistryGene TherapyNeuropathologyNeuroimmunologyHivHealthDiabetes
Publications per year
1999–2023
AAV8-vectored suprachoroidal gene transfer produces widespread ocular transgene expression
Kun Ding, Jikui Shen, Zibran Hafiz et al. · Journal of Clinical Investigation · 2019 · 131 citations · Full text
Ocular Disease, Engineering, Gene Delivery +19
Leukocyte recruitment in the brain in sepsis: involvement of the annexin 1‐FPR2/ALX anti‐inflammatory system
Felicity N. E. Gavins, Ellen L Hughes, Nicholas Buss et al. · The FASEB Journal · 2012 · 74 citations
Characterization of AAV-mediated dorsal root ganglionopathy
Nicholas Buss, Lisa G. Lanigan, Jillynne Zeller et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 69 citations · Full text
Immunology, Neuropathic Pain, Pathology +17
Potent Immune Modulation by MEDI6383, an Engineered Human OX40 Ligand IgG4P Fc Fusion Protein
Michael D. Oberst, Catherine Augé, Chad Morris et al. · Molecular Cancer Therapeutics · 2018 · 42 citations · Full text
The effect of ritonavir on saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of pharmacokinetic data from 97 subjects
J Michael Kilby, Andrew Hill, Nicholas Buss · HIV Medicine · 2002 · 36 citations · Full text
1–5 of 12